Literature DB >> 21936762

Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface.

Marion Leboyer1, Ryad Tamouza, Dominique Charron, Raphaél Faucard, Hervé Perron.   

Abstract

OBJECTIVES: Provide a synthetic review of recent studies evidencing an association between human endogenous retrovirus-W (HERV-W) and schizophrenia.
METHODS: Bibliography analysis and contextual synthesis.
RESULTS: Epidemiological studies suggest that the aetiology of schizophrenia is complex and involves a complex interplay of genetic and environmental factors such as infections. Eight percentof the human genome consists of human endogenous retroviruses (HERV), and this part of the genome was previously thought to be without importance, but new research has refuted this. HERVs share similarities with viruses and it is assumed that HERVs are present in the genome as a result of retroviruses infecting germ line cells many million years ago. A specific type of HERVs, called HERV-W, has through several recent studies been associated with schizophrenia. Elevated transcription of HERV-W elements has been documented, and antigens of HERV-W envelope and capsid proteins have been found in blood samples from patients. Viruses that have been implicated in pathology of schizophrenia, such as herpes and influenza, have been shown to activate HERV-W elements, and such activation has been associated with elevated biomarkers of systemic inflammation. New research indicates that HERV-W may be an important genetic factor interplaying with the environmental risk factor of infections and that, through this, HERV-W may be important for disease pathogenesis.
CONCLUSIONS: A lifelong scenario of a detrimental interaction between infectious agents and HERV-W genes may decipher the actual development and course of schizophrenia. Further research is needed to find out if specific treatment strategies could reduce the expression of HERV-W and if this will be associated with remission.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21936762     DOI: 10.3109/15622975.2010.601760

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  21 in total

Review 1.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 2.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

Review 3.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

Review 4.  Is it time for immunopsychiatry in psychotic disorders?

Authors:  Marion Leboyer; José Oliveira; Ryad Tamouza; Laurent Groc
Journal:  Psychopharmacology (Berl)       Date:  2016-03-18       Impact factor: 4.530

5.  A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia.

Authors:  Ellen Kure Fischer; Antonio Drago
Journal:  J Neural Transm (Vienna)       Date:  2017-05-05       Impact factor: 3.575

Review 6.  Endogenous retrovirus-K and nervous system diseases.

Authors:  Mamneet Manghera; Jennifer Ferguson; Renée Douville
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 7.  Regulatory activities of transposable elements: from conflicts to benefits.

Authors:  Edward B Chuong; Nels C Elde; Cédric Feschotte
Journal:  Nat Rev Genet       Date:  2016-11-21       Impact factor: 53.242

8.  Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate.

Authors:  Guillaume Fond; Alexandra Macgregor; Ryad Tamouza; Nora Hamdani; Alexandre Meary; Marion Leboyer; Jean-Francois Dubremetz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-06-15       Impact factor: 5.270

Review 9.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

10.  Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis.

Authors:  Ryad Tamouza; Urs Meyer; Marianne Foiselle; Jean-Romain Richard; Ching-Lieng Lu; Wahid Boukouaci; Philippe Le Corvoisier; Caroline Barrau; Alexandre Lucas; Hervé Perron; Marion Leboyer
Journal:  Transl Psychiatry       Date:  2021-07-06       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.